Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Evotec AG : Notification and public disclosure of transactions by persons

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/18/2017 | 02:05pm CEST


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

18.09.2017 / 14:01
The issuer is solely responsible for the content of this announcement.


1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Werner
Last name(s): Lanthaler

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Evotec AG

b) LEI
529900F9KI6OYITO9B12 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE0005664809

b) Nature of the transaction
Exercise against Cash Settlement
Transaction linked to the exercise of share option programmes

c) Price(s) and volume(s)
Price(s) Volume(s)
17.7711 EUR 977410.50 EUR

d) Aggregated information
Price Aggregated volume
17.7711 EUR 977410.50 EUR

e) Date of the transaction
2017-09-15; UTC+2

f) Place of the transaction
Outside a trading venue



18.09.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Evotec AG
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Internet: www.evotec.com

 
End of News DGAP News Service

37749  18.09.2017 


© EQS 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EVOTEC AG
08/16EVOTEC AG : reports first half-year 2018 results and corporate updates
AQ
08/16EVOTEC : Partner Haplogen Enters into Collaboration with Bayer
AQ
08/14EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
08/14EVOTEC AG : Evotec Partner Haplogen Enters Into Collaboration With Bayer
AC
08/14EVOTEC : Partner haplogen enters into collaboration with bayer
EQ
08/13EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
08/09EVOTEC AG : to report first half-year 2018 results on 09 August 2018
AQ
08/09EVOTEC AG : Reports First Half-Year 2018 Results And Corporate Updates
AC
08/09EVOTEC : Reports first half-year 2018 results and corporate updates
EQ
08/03EVOTEC : repays 50% of EUR 140 m acquisition loan
AQ
More news
News from SeekingAlpha
08/12Evotec AG 2018 Q2 - Results - Earnings Call Slides 
08/12Evotec AG (EVOTF) CEO Werner Lanthaler on Q2 2018 Results - Earnings Call Tra.. 
08/09Evotec AG reports Q2 results 
05/31Evotec forms LAB591 with Arix Bioscience and Fred Hutchinson Cancer Research .. 
05/21Celgene teams up with Evotec to discover new cancer treatments 
Financials (€)
Sales 2018 353 M
EBIT 2018 46,6 M
Net income 2018 34,2 M
Debt 2018 80,3 M
Yield 2018 -
P/E ratio 2018 87,06
P/E ratio 2019 64,44
EV / Sales 2018 8,77x
EV / Sales 2019 7,79x
Capitalization 3 019 M
Chart EVOTEC AG
Duration : Period :
Evotec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 20,1 €
Spread / Average Target -2,0%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Mario Eugenio Cosimino Polywka Chief Operating Officer
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC AG51.56%3 453
CELLTRION, INC.--.--%29 483
IQVIA HOLDINGS INC22.86%24 367
LONZA GROUP17.93%23 220
INCYTE CORPORATION-27.36%14 625
SEATTLE GENETICS, INC.39.51%11 852